Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India

CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology

LTS acquires Sorrel wearable injection device business

The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.

Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions

Franson will help biopharma clients design a phased approach to inform and execute clinical development plans

Bridgewest Group launches new sterile injectable CDMO NovaCina

Microbion gets US patent for the use of inhaled pravibismane for pulmonary infections

Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039

GSK and SCYNEXIS announce agreement to commercialise and further develop Brexafemme

SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties

Getinge to boost scalability and deepen healthcare access in India

Getinge has a strong market share in India within several product segments

MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine

Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers

Emmes acquires Essex Management

Essex enriches and complements Emmes’ services

Zydus granted Orphan Drug Designation by USFDA for ZYIL1

ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates